Chemed: Empire of Care - Business Breakdowns Recap
Podcast: Business Breakdowns
Published: 2025-05-01
Duration: 45 min
Summary
Chemed operates two distinct businesses—VITAS Healthcare and Roto-Rooter—under a single corporate umbrella, leveraging intentional capital allocation to achieve a 21% EPS CAGR since 2003. The episode explores how these seemingly unrelated sectors can maximize shareholder value.
What Happened
In this episode of Business Breakdowns, host Zach Bust and guest Chad Garcia delve into the unique structure of Chemed Corporation, which combines end-of-life healthcare through VITAS and plumbing services via Roto-Rooter. The discussion highlights how Chemed's intentional capital allocation strategy has led to significant financial growth, boasting a market cap of $8.5 billion and generating approximately $3.7 billion in free cash flow since 2004. This strategic allocation has allowed Chemed to buy back $2.5 billion worth of its own stock, significantly reducing its share count from 25 million to 15 million.
Garcia offers insights into the history of Chemed, tracing its origins back to a spinoff from W.R. Grace in the 1970s. This led to the acquisition of Roto-Rooter in 1980 and the later purchase of VITAS Healthcare in 2004. The contrasting natures of these two businesses—one highly regulated and personal, the other demand-driven and widely recognized—are explored in depth. Garcia emphasizes how the management team has prioritized growing free cash flow per share, remaining agnostic about the specific operations involved, which has allowed for flexibility in their business strategy. This adaptability positions Chemed favorably within its competitive landscapes, catering effectively to both healthcare and plumbing sectors.
Key Insights
- Chemed's intentional capital allocation has resulted in impressive financial growth.
- The combination of VITAS and Roto-Rooter allows for diversified revenue streams.
- Chemed prioritizes free cash flow growth over industry-specific constraints.
- The management's ability to adapt and pivot is a key to Chemed's success.
Key Questions Answered
How did Chemed acquire Roto-Rooter?
Chemed acquired Roto-Rooter in the 1980s as part of a series of corporate transactions. After spinning off its specialty chemicals business, Chemed identified Roto-Rooter as a strategic acquisition that complemented its operations. Garcia notes that the management's approach to acquisition was driven by the potential for high returns and the demand for plumbing services.
What is VITAS Healthcare's role in Chemed?
VITAS Healthcare serves as Chemed's key player in the end-of-life hospice care sector. Founded in 1978, VITAS has grown to become a leading provider in the U.S. hospice market. The management team at Chemed recognized the importance of this segment when they decided to acquire a larger stake in VITAS, which was initially financed through convertible debt, allowing them to capture significant growth in this deeply personal and regulated industry.
What are the financial highlights of Chemed Corporation?
Chemed Corporation boasts a market cap of $8.5 billion, with revenues approaching $2.5 billion and EBITDA between $500 to $600 million. Since 2004, the company has generated around $3.7 billion in free cash flow, after accounting for capital expenditures. The strategic focus on capital allocation has enabled Chemed to return substantial capital to shareholders through stock buybacks and a small but growing dividend.
How does Chemed manage its diverse business model?
Chemed's management emphasizes flexibility in their operational strategy, being agnostic about the specific industries they operate in. This approach allows them to maximize free cash flow per share regardless of whether it's from VITAS or Roto-Rooter. The management's focus on growing free cash flow has been a guiding principle that has led to substantial financial performance and shareholder value.
What makes Chemed's capital allocation strategy successful?
Chemed's capital allocation strategy has proven successful due to its disciplined approach to managing operations and investments. The company has historically prioritized reinvesting cash flow into high-return projects while also returning capital to shareholders through dividends and stock buybacks. This balance of growth and shareholder return is a key aspect of what has driven its impressive 21% EPS CAGR since 2003.